Supercharge Your Innovation With Domain-Expert AI Agents!

A kind of preparation method of voriconazole and its intermediate

A technology of voriconazole and its intermediates, applied in the field of medicinal chemistry, can solve the problems that the utilization rate of raw and auxiliary materials cannot be greatly improved, the requirements of cost control cannot be met, and the improvement range is limited, so as to achieve easy large-scale industrial production, low cost, and improved utilization rate effect

Active Publication Date: 2018-08-24
重庆莱美隆宇药业有限公司
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Using this strategy to prepare voriconazole has the advantage that (2R, 3S) isomers account for a relatively high proportion (generally greater than 50%), but there are currently the following problems. One is in the process of asymmetric synthesis of voriconazole or its intermediates , it is necessary to use transition metal catalysts that are expensive and difficult to obtain in large quantities (such as bistriphenylphosphine palladium dichloride (II), CuF (PPh3) 2) and chiral ligands ((S)-1-((SP )-2-[2-(diphenylphosphino)phenyl]ferrocenyl)ethylbis[3,5-bis(trifluoromethyl)phenyl]phosphine), at present, this method is still in experimental The small-scale preparation of voriconazole samples in the laboratory cannot meet the requirements of industrial production for cost control
The second is that although voriconazole is prepared by asymmetric synthesis, the content ratio of (2R, 3S) isomers is increased, but due to the selectivity of asymmetric synthesis, the increase range is limited. In the prepared voriconazole, the isomer impurities (2S ,3R) content can still account for (5% to 30%), so if it is necessary to finally obtain a voriconazole product with qualified isomer impurity content, subsequent purification still needs to be resolved
[0005] To sum up, using the above method to prepare the compound of formula I, due to the limitation of theory and large-scale production on cost control, although some parameters can be optimized, in the process of industrial production, it is still impossible to greatly improve the utilization rate of raw materials and auxiliary materials, and then obtain a higher yield. Voriconazole bulk drug with high production cost and lower production cost. For this reason, a new technical solution is urgently needed to provide better process conditions, improve the utilization rate of raw and auxiliary materials, reduce resource waste and protect the environment, and reduce production costs to the greatest extent. It is more conducive to large-scale industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of voriconazole and its intermediate
  • A kind of preparation method of voriconazole and its intermediate
  • A kind of preparation method of voriconazole and its intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] A preparation method of voriconazole intermediate, which is characterized in that it comprises the following steps: taking voriconazole isomers (2S, 3R) as raw materials, taking 157.5g of raw materials, and reacting in NaOH aqueous solution, the concentration of NaOH is 2mol / L, The reaction temperature is 50°C, and the reaction time is 5 hours. After the reaction, the reaction mixture is cooled, and the mixture of compound II and compound III is first extracted with ethyl acetate, and then concentrated to obtain compound III, and then the collected is concentrated The liquid is subjected to atmospheric distillation to obtain compound II. The LC / MS spectra of compound Ⅱ and compound Ⅲ are attached Figure 5 with 6 .

Embodiment 2

[0037] A preparation method of voriconazole, which is characterized in that it comprises the following steps: taking voriconazole isomers (2S, 3R) as raw materials, taking 157.5 g of raw materials, and reacting in an aqueous NaOH solution, the concentration of NaOH is 1 mol / L, and the reaction temperature The temperature is 50°C and the reaction time is 7 hours. After the reaction, the reaction mixture is cooled and extracted with ethyl acetate to obtain a mixture of compound II and compound III, and then concentrated to obtain compound III, and then the collected concentrate is subjected to normal Pressure distillation to obtain compound II. The compound II was brominated with NBS (refer to the corresponding literature) to obtain 4-(1-bromoethyl)-5-fluoropyrimidine. Then add the reaction reagent, and carry out the Reformatsky reaction and condensation reaction with compound Ⅲ to prepare the racemate of voriconazole, and then add the chiral reagent (L)-camphor-10-sulfonic acid ...

Embodiment 3

[0039] A preparation method of voriconazole intermediate, which is characterized in that it comprises the following steps: taking a mixture of voriconazole isomers (2R, 3R / 2S, 3S / 2S, 3R) as raw materials, taking 174.5 g of raw materials, and reacting in NaOH aqueous solution The concentration of NaOH is 5mol / L, the reaction temperature is 45℃, and the reaction time is 3 hours. After the reaction, the reaction mixture is cooled and extracted with dichloromethane to obtain a mixture of compound II and compound III, and then concentrated to obtain the compound Ⅲ, and then carry out atmospheric distillation on the collected concentrated liquid fraction to obtain compound Ⅱ. The mass spectra of compound Ⅱ and compound Ⅲ are attached Figure 5 with 6 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides Voriconazole prepared from Voriconazole isomers and a preparation method of an intermediate of the Voriconazole. According to the method, the Voriconazole isomers are used as raw materials, under the condition of an alkaline reaction and 25-100 DEG C, reaction is performed for 1-24 hours, and then a condensation reaction is performed, so that a Voriconazole despinner is prepared; and chiral separation is performed on the Voriconazole despinner, so that the Voriconazole is obtained. According to the method, massive waste Voriconazole isomers generated in an industrialized production process can be recycled, and waste of raw auxiliary materials and resources in the preparation process of the Voriconazole can be avoided. Not only can the production cost be greatly reduced, but also recycling production can also be developed, so that the purposes of saving resources and protecting environment can be achieved.

Description

Technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a new preparation method of the second generation triazole antifungal drug voriconazole and its intermediates for treating acute or chronic deep fungal infections. Background technique [0002] Voriconazole is a chiral drug with two chiral centers in its molecule and four isomers. They are (2R, 3S / 2S, 3R) and (2S, 3S / 2R, 3R). The structure-activity relationship study (SAR) confirmed that the antibacterial activity of the (2R, 3S / 2S, 3R) enantiomer is more than 200 times that of the (2S, 3S / 2R, 3R) enantiomer. Further experimental studies on the resolution of a pair of enantiomers with good activity (2R, 3S / 2S, 3R) showed that a single isomer (2R, 3S), namely voriconazole. The inhibitory activity against Aspergillus (fungi) is more than 200 times that of the (2S, 3R) isomer, and compared with (2S, 3R), the isomer (2R, 3S) has a broader antibacterial spectrum. The active ingredient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D403/06C07D249/08
CPCC07D249/08C07D403/06
Inventor 黄文峰李胜伟黄雄鸠马缙周和平
Owner 重庆莱美隆宇药业有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More